DNA-PK As an Emerging Therapeutic Target in Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Aug 6

PMID 31380275

Citations 98

Authors

Ismail S Mohiuddin

Min H Kang

Affiliations

Soon will be listed here.

Abstract

The DNA-dependent protein kinase (DNA-PK) plays an instrumental role in the overall survival and proliferation of cells. As a member of the phosphatidylinositol 3-kinase-related kinase (PIKK) family, DNA-PK is best known as a mediator of the cellular response to DNA damage. In this context, DNA-PK has emerged as an intriguing therapeutic target in the treatment of a variety of cancers, especially when used in conjunction with genotoxic chemotherapy or ionizing radiation. Beyond the DNA damage response, DNA-PK activity is necessary for multiple cellular functions, including the regulation of transcription, progression of the cell cycle, and in the maintenance of telomeres. Here, we review what is currently known about DNA-PK regarding its structure and established roles in DNA repair. We also discuss its lesser-known functions, the pharmacotherapies inhibiting its function in DNA repair, and its potential as a therapeutic target in a broader context.

Citing Articles

Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner.

Arnold M, Chen S, Unni V bioRxiv. 2024; .

PMID: 39677631 PMC: 11642733. DOI: 10.1101/2024.12.01.626256.

Disruption of RNA Splicing Increases Vulnerability of Cells to DNA-PK Inhibitors.

Kovina A, Luzhin A, Tatarskiy V, Deriglazov D, Petrova N, Petrova N Int J Mol Sci. 2024; 25(21).

PMID: 39519361 PMC: 11546466. DOI: 10.3390/ijms252111810.

DNA damage caused by chemotherapy has duality, and traditional Chinese medicine may be a better choice to reduce its toxicity.

Bai B, Ma Y, Liu D, Zhang Y, Zhang W, Shi R Front Pharmacol. 2024; 15:1483160.

PMID: 39502534 PMC: 11534686. DOI: 10.3389/fphar.2024.1483160.

Secrets of DNA-PKcs beyond DNA repair.

Camfield S, Chakraborty S, Dwivedi S, Pramanik P, Mukherjee P, Bhattacharya R NPJ Precis Oncol. 2024; 8(1):154.

PMID: 39043779 PMC: 11266574. DOI: 10.1038/s41698-024-00655-1.

DNA break induces rapid transcription repression mediated by proteasome-dependent RNAPII removal.

He S, Huang Z, Liu Y, Ha T, Wu B Cell Rep. 2024; 43(7):114420.

PMID: 38954517 PMC: 11337244. DOI: 10.1016/j.celrep.2024.114420.

References

Shao R, Cao C, Zhang H, Kohn K, Wold M, Pommier Y . Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J. 1999; 18(5):1397-406. PMC: 1171229. DOI: 10.1093/emboj/18.5.1397. View

Smith G, Jackson S . The DNA-dependent protein kinase. Genes Dev. 1999; 13(8):916-34. DOI: 10.1101/gad.13.8.916. View

Tuteja R, Tuteja N . Ku autoantigen: a multifunctional DNA-binding protein. Crit Rev Biochem Mol Biol. 2000; 35(1):1-33. DOI: 10.1080/10409230091169177. View

Koike M, Shiomi T, Koike A . Dimerization and nuclear localization of ku proteins. J Biol Chem. 2001; 276(14):11167-73. DOI: 10.1074/jbc.M010902200. View

Espejel S, Franco S, Sgura A, Gae D, Bailey S, Taccioli G . Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J. 2002; 21(22):6275-87. PMC: 137185. DOI: 10.1093/emboj/cdf593. View

Hollick J, Golding B, Hardcastle I, Martin N, Richardson C, Rigoreau L . 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK). Bioorg Med Chem Lett. 2003; 13(18):3083-6. DOI: 10.1016/s0960-894x(03)00652-8. View

Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K . Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci. 2003; 94(10):894-900. PMC: 11160163. DOI: 10.1111/j.1349-7006.2003.tb01372.x. View

Allen C, Halbrook J, Nickoloff J . Interactive competition between homologous recombination and non-homologous end joining. Mol Cancer Res. 2003; 1(12):913-20. View

Stiff T, ODriscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo P . ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004; 64(7):2390-6. DOI: 10.1158/0008-5472.can-03-3207. View

10.

Bailey S, Brenneman M, Halbrook J, Nickoloff J, Ullrich R, Goodwin E . The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst). 2004; 3(3):225-33. DOI: 10.1016/j.dnarep.2003.10.013. View

11.

Jaco I, Munoz P, Blasco M . Role of human Ku86 in telomere length maintenance and telomere capping. Cancer Res. 2004; 64(20):7271-8. DOI: 10.1158/0008-5472.CAN-04-1381. View

12.

Douglas P, Gupta S, Morrice N, Meek K, Lees-Miller S . DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining. DNA Repair (Amst). 2005; 4(9):1006-18. DOI: 10.1016/j.dnarep.2005.05.003. View

13.

Iijima S, Teraoka H, Date T, Tsukada K . DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. Eur J Biochem. 1992; 206(2):595-603. DOI: 10.1111/j.1432-1033.1992.tb16964.x. View

14.

Fisher T, Zakian V . Ku: a multifunctional protein involved in telomere maintenance. DNA Repair (Amst). 2005; 4(11):1215-26. DOI: 10.1016/j.dnarep.2005.04.021. View

15.

Lee S, Cho K, Park J, Kim S, Nam S, Lee B . Expressions of Ku70 and DNA-PKcs as prognostic indicators of local control in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2005; 62(5):1451-7. DOI: 10.1016/j.ijrobp.2004.12.049. View

16.

Hardcastle I, Cockcroft X, Curtin N, El-Murr M, Leahy J, Stockley M . Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem. 2005; 48(24):7829-46. DOI: 10.1021/jm050444b. View

17.

Cui X, Yu Y, Gupta S, Cho Y, Lees-Miller S, Meek K . Autophosphorylation of DNA-dependent protein kinase regulates DNA end processing and may also alter double-strand break repair pathway choice. Mol Cell Biol. 2005; 25(24):10842-52. PMC: 1316975. DOI: 10.1128/MCB.25.24.10842-10852.2005. View

18.

Zhao Y, Thomas H, Batey M, Cowell I, Richardson C, Griffin R . Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 2006; 66(10):5354-62. DOI: 10.1158/0008-5472.CAN-05-4275. View

19.

Spagnolo L, Rivera-Calzada A, Pearl L, Llorca O . Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol Cell. 2006; 22(4):511-9. DOI: 10.1016/j.molcel.2006.04.013. View

20.

Ju B, Lunyak V, Perissi V, Garcia-Bassets I, Rose D, Glass C . A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science. 2006; 312(5781):1798-802. DOI: 10.1126/science.1127196. View